231 related articles for article (PubMed ID: 15682444)
21. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
22. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
23. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
Włodarczyk J; Stolte M; Mueller J
Pol J Pathol; 2001; 52(3):119-24. PubMed ID: 11769398
[TBL] [Abstract][Full Text] [Related]
25. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
26. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
27. Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction.
Wijnhoven BP; Tucker ET; Dinjens WN; Tilanus HW; Pignatelli M
Anticancer Res; 2004; 24(3a):1369-75. PubMed ID: 15274297
[TBL] [Abstract][Full Text] [Related]
28. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
29. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
[TBL] [Abstract][Full Text] [Related]
30. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A
Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126
[TBL] [Abstract][Full Text] [Related]
31. Expression of E-cadherin and alpha- and beta-catenins in thymoma.
Pan CC; Ho DM; Chen WY; Chiang H; Fahn HJ; Wang LS
J Pathol; 1998 Feb; 184(2):207-11. PubMed ID: 9602713
[TBL] [Abstract][Full Text] [Related]
32. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
33. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
[TBL] [Abstract][Full Text] [Related]
34. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
[TBL] [Abstract][Full Text] [Related]
35. Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways.
Noë V; Chastre E; Bruyneel E; Gespach C; Mareel M
Biochem Soc Symp; 1999; 65():43-62. PubMed ID: 10320932
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
38. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
[TBL] [Abstract][Full Text] [Related]
40. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
Mahomed F; Altini M; Meer S
Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
